The Fund seeks long-term growth of capital. The Fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary.
| Classification | Inception Date | Primary Exchange |
|---|---|---|
| Health/Biotech Funds | 10/31/2014 | Cboe BZX |
Investment Information
| Market Cap | 2.38B |
| Net Assets | 2.25B |
| NAV | 35.26 |
| Shares Outstanding | 67.35M |
| Avg Daily Vol | 1.64M |
| Dividend Yield | 0.00% |
| Dividend | 0.38 |
| Ex Dividend Date | 12/29/21 |
Detailed Information
| Mgmt Co | ARK Invest |
| Turnover | 51.00% |
| Beta | 1.26 |
| P/E | 38.23 |
| P/B | 3.87 |
| Expense Ratio | 0.75% |
To receive a prospectus
ARK Invest3 E 28th Street
7th Floor
New York, NY 10016
Performance
| ARKG | S&P 500 TR IX | |
|---|---|---|
| 1 week | 3.66 | 1.64 |
| 4 weeks | 24.81 | 6.29 |
| 3 months | 8.32 | 10.17 |
| 1 year | -25.75 | -6.07 |
| 3 years | 2.57 | 10.16 |
| 5 years | 7.20 | 10.34 |
